Katrina Rios Rojas

Impact-oriented technologist & product person @awscloud, former @FlatironHealth @ASCO @SceneHealth | 🇵🇷 / 🇨🇺 | Tweets are my own.

[Jorge Conde @JorgeCondeBio]

Biotech is having a tech moment.

@JayRughani & I wrote about the whitespace opportunities for better software for science.

Here’s my initial sketch of the idea for the piece (dramatically improved by the brilliant @a16z design team) ✍️

How it started: How it’s going:

[Robert S Miller, MD, FACP, FASCO, FAMIA-he/him @rsm2800]

"We must bring the trial to the patient and can no longer expect the patient to come to the trial" #ASCO22

[Ana I. Velázquez Mañana, MD, MSc, FASCO @AnaVManana]

Full house watching the amazing @jillfeldman4 highlighting the importance of always engaging patients in trial design, outcomes selection, & the importance of real world data & lived experience of patients
#ASCO22 #LCSM @EGFRResisters

[Flatiron Health @flatironhealth]

Our #ASCO22 research demonstrates the latest applications of EHR-derived #RWD to advance #cancer care & importance of health equity research.

Learn more from the authors!
https://t.co/ig2blxrk8q

Also proud to see Flatiron data utilized in 35 other @ASCO abstracts.

[Dr. Estela Rodriguez @Latinamd]

#ASCO22 #HealthEquity It is just bad science when clinical trials don't include the patients who are most impacted by the mutations & diseases we are interested in.
@SukiPaddaMD discusses lack of diversity in landmark #lungcancer IO and KRASm clinical trials. #lcsm #diversity

[Katrina Rios Rojas @katcrios]

Reading Mountains Beyond Mountains led me to pursue a career in public health & re-reading it inspired me to think about creative ways I could impact healthcare at scale📚⛰️

Extra grateful to see this @ #ASCO22 as someone who started in TB before moving into oncology!

[Mark Lewis, MD, FASCO @marklewismd]

.⁦@aparna1024⁩ pays tribute to the late Dr Paul Farmer by observing that the core principle of global health is that no lives matter less than others #asco22

[Liz Garrett-Mayer, PhD @LGM_Biostats]

@NealMeropol from @flatironhealth talking about the power of technology to make it easier for all of us to participate in research at #ASCO22. 70% of info needed for clinical trial data is already in EHRs. Reduce costs & increase evidence generation by leveraging the EHR!

[Katrina Rios Rojas @katcrios]

When you are following #ASCO22 from the Twitter sidelines for the 3rd year in a row & want to make it fashion from your apartment 💙 🎈

[Katrina Rios Rojas @katcrios]

That feeling when you've been away from #onctwitter for a while to get through a few crazy months & return as a new product manager at @flatironhealth 🙌 So grateful to be back in the oncology RWE space to serve people w/ cancer through technology!

[Katrina Rios Rojas @katcrios]

@AnaVManana @Lin_Manuel 💯💯💯💯💯

I am actually still crying the happiest of tears 😭 Nina's storyline... OOOF, I felt that so hard

[Katrina Rios Rojas @katcrios]

"Within my local support group, we meet and share our stories to both lift each other up and educate one another. CancerLinQ can offer oncologists what my local support group offered to me—but on a significantly larger scale"

.@JackMAiello beautiful perspective!

#mmsm #ASCO21

[CancerLinQ® @CancerLinQOrg]

@JackMAiello is a member of CancerLinQ's Patient Advisory Committee. Read about his journey with #multiplemyeloma and his view of #CancerLinQ's impact on the patient journey.
https://t.co/UIShd5m5I6

[Ana I. Velázquez Mañana, MD, MSc, FASCO @AnaVManana]

🚨 My take-home point:

Every patient should have access to transportation, cancer care, navigation services, and supportive care

How do you do that?

INVEST in engaging communities & diversifying your workforce to narrow disparities

#ASCO21 #DumaLab #equity #healthdisparities

[Ana I. Velázquez Mañana, MD, MSc, FASCO @AnaVManana]

Join now: https://t.co/jLWzzU5hcZ

Outstanding talk by @rtdess @UMRogelCancer on #sdoh not biology as drivers in racial #disparities using #pcsm as example

#ASCO21 @ASCO

[Charu Aggarwal, MD, MPH, FASCO @CharuAggarwalMD]

Only 50% of #NSCLC pts getting tested for immediately actionable mutations should be shocking to everyone. We need to deliver better quality care #LCSM #ASCO21 @ASCO #PersonalizedMedicine

[Katrina Rios Rojas @katcrios]

In oncology, clinical teams collaborating w/ #product is extra important to ensure all of the promising advances coming out are translated into delightful user experiences that solve real problems!

A 30 min call to understand problems & pain points goes SUCH a long way.

#ASCO21

[Katrina Rios Rojas @katcrios]

🧵How can BIPOC #product managers help advance #healthequity in oncology & beyond?

Product managers solve user problems from a foundation of empathy to deploy solutions that help people. We align business, tech, user, & stakeholder needs to make things happen.

#ASCO21

[Katrina Rios Rojas @katcrios]

Having a BIPOC person in a #product role when these decisions are being made helps identify bias + present user-centered alternatives upfront in the development process to ensure solutions equitably help people w/ chronic and/or acute conditions.

#ASCO21

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@katcrios What a great question!
Sponsors/Sites are made of people, who need to come together (at #ASCO21 ?)

Join the conversation:
- Social media?
- Joint task force, white paper?
- Statements by regulatory bodies?
- Promote the voice of patient advocates

[Katrina Rios Rojas @katcrios]

@AnaVManana @NarjustDumaMD @ASCO @Latinamd @LatinasInMed @fumikochino @COlazagasti @IvyRadOncMD @GlopesMd @tmprowell @RodriguezGIMD @DrSGraff @montypal As a Latina who did not pursue clinical medicine as my career path for many of the same reasons described in this session, I'm so happy to see this being highlighted at @ASCO as another step for positive culture change in medicine + sending big hugs to #LatinasInMedicine #ASCO21